Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,442 | 326 | 60.3% |
| Travel and Lodging | $4,516 | 17 | 32.3% |
| Education | $1,031 | 12 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $3,564 | 44 | $0 (2024) |
| Intuitive Surgical, Inc. | $2,520 | 20 | $0 (2019) |
| Astellas Pharma US Inc | $1,873 | 58 | $0 (2024) |
| Boston Scientific Corporation | $867.55 | 10 | $0 (2024) |
| ABBVIE INC. | $610.39 | 27 | $0 (2024) |
| Axonics, Inc. | $449.97 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $430.26 | 13 | $0 (2024) |
| PFIZER INC. | $386.42 | 19 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $349.99 | 15 | $0 (2024) |
| UROVANT SCIENCES INC | $331.33 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,431 | 73 | Teleflex LLC ($706.65) |
| 2023 | $2,497 | 61 | Teleflex LLC ($1,591) |
| 2022 | $1,788 | 61 | Astellas Pharma US Inc ($680.19) |
| 2021 | $2,109 | 55 | Teleflex LLC ($1,060) |
| 2020 | $593.49 | 29 | Astellas Pharma US Inc ($130.73) |
| 2019 | $3,287 | 43 | Intuitive Surgical, Inc. ($2,520) |
| 2018 | $1,046 | 31 | NeoTract Inc. ($194.94) |
| 2017 | $236.98 | 2 | BOSTON SCIENTIFIC CORPORATION ($125.00) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $41.40 | General |
| 12/19/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/11/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $142.00 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/06/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 11/08/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 09/26/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $78.99 | General |
| 09/26/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: rezum_URO | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: HORMONE THERAPY | ||||||
| 08/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $67.44 | General |
| 08/01/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 719 | 877 | $234,495 | $69,064 |
| 2022 | 18 | 806 | 973 | $184,560 | $61,296 |
| 2021 | 21 | 933 | 1,231 | $189,408 | $64,305 |
| 2020 | 19 | 831 | 1,060 | $163,963 | $49,656 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 96 | 113 | $85,250 | $19,684 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 126 | $26,460 | $11,204 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $22,680 | $7,801 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 109 | $15,369 | $6,296 | 41.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 30 | 31 | $24,800 | $5,700 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $8,207 | $3,718 | 45.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 13 | 13 | $9,750 | $2,960 | 30.4% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 14 | 14 | $5,754 | $2,202 | 38.3% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 14 | 55 | $5,555 | $2,093 | 37.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,860 | $1,676 | 34.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 30 | 31 | $10,478 | $1,382 | 13.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 59 | 75 | $3,825 | $1,352 | 35.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 14 | $2,870 | $1,261 | 44.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 81 | 102 | $5,100 | $707.17 | 13.9% |
| 51610 | Injection procedure through bladder and urethra for x-ray imaging | Facility | 2023 | 11 | 15 | $2,025 | $360.09 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 39 | $780.00 | $327.60 | 42.0% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 11 | 16 | $576.00 | $296.40 | 51.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $156.00 | $44.33 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 136 | $28,560 | $12,375 | 43.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 55 | 69 | $51,750 | $12,176 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 56 | $15,848 | $7,482 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $14,256 | $5,489 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 80 | $11,280 | $5,144 | 45.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 46 | 48 | $9,935 | $4,328 | 43.6% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 21 | 21 | $16,800 | $3,986 | 23.7% |
About Dr. James Belarmino, MD
Dr. James Belarmino, MD is a Urology healthcare provider based in Latham, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1649447897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Belarmino, MD has received a total of $13,989 in payments from pharmaceutical and medical device companies, with $2,431 received in 2024. These payments were reported across 355 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,442).
As a Medicare-enrolled provider, Belarmino has provided services to 3,289 Medicare beneficiaries, totaling 4,141 services with total Medicare billing of $244,321. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Latham, NY
- Active Since 05/15/2008
- Last Updated 03/04/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1649447897
Products in Payments
- Da Vinci Surgical System (Device) $2,520
- UROLIFT (Device) $2,075
- UroLift System (Device) $1,185
- GREENLIGHT (Device) $713.54
- XTANDI (Drug) $574.92
- Xtandi (Drug) $501.99
- GEMTESA (Drug) $444.43
- KEYTRUDA (Biological) $396.88
- BOTOX (Biological) $365.25
- Axonics (Device) $356.87
- ORGOVYX (Drug) $256.71
- ELIGARD (Drug) $238.77
- LUPRON DEPOT (Drug) $217.84
- Axonics r-SNM System (Device) $169.66
- Myrbetriq (Drug) $138.03
- UroLift (Device) $135.88
- Noctiva (Drug) $131.95
- iTIND System (Device) $125.48
- MYRBETRIQ (Drug) $116.42
- Erleada (Drug) $114.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Latham
Dr. Matthew Stringer, D.o, D.O
Urology — Payments: $6,223
Dr. Zachary Passaretti, Md, MD
Urology — Payments: $6,117
Dr. Carla Beckham, Md/Phd, MD/PHD
Urology — Payments: $3,098
Dr. Efrossini Kolios, Md, MD
Urology — Payments: $2,610
Yoram Beer, Md, MD
Urology — Payments: $2,125
Dr. Donald Bentrovato, Md, MD
Urology